167 related articles for article (PubMed ID: 38466744)
1. Autocrine phosphatase PDP2 inhibits ferroptosis by dephosphorylating ACSL4 in the Luminal A Breast Cancer.
Zhu JJ; Huang FY; Chen H; Zhang YL; Chen MH; Wu RH; Dai SZ; He GS; Tan GH; Zheng WP
PLoS One; 2024; 19(3):e0299571. PubMed ID: 38466744
[TBL] [Abstract][Full Text] [Related]
2. Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy.
Sha R; Xu Y; Yuan C; Sheng X; Wu Z; Peng J; Wang Y; Lin Y; Zhou L; Xu S; Zhang J; Yin W; Lu J
EBioMedicine; 2021 Sep; 71():103560. PubMed ID: 34482070
[TBL] [Abstract][Full Text] [Related]
3. High-fat diet impairs ferroptosis and promotes cancer invasiveness via downregulating tumor suppressor ACSL4 in lung adenocarcinoma.
Zhang Y; Li S; Li F; Lv C; Yang QK
Biol Direct; 2021 May; 16(1):10. PubMed ID: 34053456
[TBL] [Abstract][Full Text] [Related]
4. Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1.
Miao Z; Tian W; Ye Y; Gu W; Bao Z; Xu L; Sun G; Li C; Tu Y; Chao H; Lam SM; Liu N; Ji J
Cell Death Dis; 2022 Jun; 13(6):548. PubMed ID: 35697672
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Biological Significances of a Ferroptosis-Related Gene Signature in Lung Cancer Based on Deep Learning.
Yang X; Hu X; Guo N
Comput Math Methods Med; 2022; 2022():6495301. PubMed ID: 36060648
[TBL] [Abstract][Full Text] [Related]
6. ALKBH5 targets ACSL4 mRNA stability to modulate ferroptosis in hyperbilirubinemia-induced brain damage.
Zhou J; Tang J; Zhang C; Li G; Lin X; Liao S; Luo J; Yu G; Zheng F; Guo Z; Shao W; Hu H; Xu L; Wu S; Li H
Free Radic Biol Med; 2024 Aug; 220():271-287. PubMed ID: 38734267
[TBL] [Abstract][Full Text] [Related]
7. ACSL4: a double-edged sword target in multiple myeloma, promotes cell proliferation and sensitizes cell to ferroptosis.
Zhang J; Liu Y; Li Q; Zuo L; Zhang B; Zhao F; Fan F; Luo S; Hu Y; Sun C
Carcinogenesis; 2023 May; 44(3):242-251. PubMed ID: 36999754
[TBL] [Abstract][Full Text] [Related]
8. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.
Li Y; Feng D; Wang Z; Zhao Y; Sun R; Tian D; Liu D; Zhang F; Ning S; Yao J; Tian X
Cell Death Differ; 2019 Nov; 26(11):2284-2299. PubMed ID: 30737476
[TBL] [Abstract][Full Text] [Related]
9. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury.
Wang Y; Zhang M; Bi R; Su Y; Quan F; Lin Y; Yue C; Cui X; Zhao Q; Liu S; Yang Y; Zhang D; Cao Q; Gao X
Redox Biol; 2022 May; 51():102262. PubMed ID: 35180475
[TBL] [Abstract][Full Text] [Related]
10. ACSL4 contributes to ferroptosis-mediated rhabdomyolysis in exertional heat stroke.
He S; Li R; Peng Y; Wang Z; Huang J; Meng H; Min J; Wang F; Ma Q
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1717-1730. PubMed ID: 35243801
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
Xu Y; Li X; Cheng Y; Yang M; Wang R
FASEB J; 2020 Dec; 34(12):16262-16275. PubMed ID: 33070393
[TBL] [Abstract][Full Text] [Related]
12. PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis.
Zhang HL; Hu BX; Li ZL; Du T; Shan JL; Ye ZP; Peng XD; Li X; Huang Y; Zhu XY; Chen YH; Feng GK; Yang D; Deng R; Zhu XF
Nat Cell Biol; 2022 Jan; 24(1):88-98. PubMed ID: 35027735
[TBL] [Abstract][Full Text] [Related]
13. ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation.
Cui Y; Zhang Y; Zhao X; Shao L; Liu G; Sun C; Xu R; Zhang Z
Brain Behav Immun; 2021 Mar; 93():312-321. PubMed ID: 33444733
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of SHP2 attenuated LPS-induced ferroptosis via downregulating ACSL4 expression in acute lung injury.
Li B; Wang Z; Yuan J; Liang D; Cheng Y; Wang Z
Allergol Immunopathol (Madr); 2023; 51(3):143-152. PubMed ID: 37169572
[TBL] [Abstract][Full Text] [Related]
15. Repositioning of FDA-Approved antifungal agents to interrogate Acyl-CoA synthetase long chain family member 4 (ACSL4) in ferroptosis.
Marteau R; Ravez S; Mazhari Dorooee D; Bouchaoui H; Porte K; Devedjian JC; Melnyk P; Devos D; Frédérick R; El Bakali J
Biochem Pharmacol; 2022 Oct; 204():115239. PubMed ID: 36075462
[TBL] [Abstract][Full Text] [Related]
16. LPCAT3 Is Transcriptionally Regulated by YAP/ZEB/EP300 and Collaborates with ACSL4 and YAP to Determine Ferroptosis Sensitivity.
Cui J; Wang Y; Tian X; Miao Y; Ma L; Zhang C; Xu X; Wang J; Fang W; Zhang X
Antioxid Redox Signal; 2023 Sep; 39(7-9):491-511. PubMed ID: 37166352
[No Abstract] [Full Text] [Related]
17. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
[TBL] [Abstract][Full Text] [Related]
18. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.
Doll S; Proneth B; Tyurina YY; Panzilius E; Kobayashi S; Ingold I; Irmler M; Beckers J; Aichler M; Walch A; Prokisch H; Trümbach D; Mao G; Qu F; Bayir H; Füllekrug J; Scheel CH; Wurst W; Schick JA; Kagan VE; Angeli JP; Conrad M
Nat Chem Biol; 2017 Jan; 13(1):91-98. PubMed ID: 27842070
[TBL] [Abstract][Full Text] [Related]
19. ACSL4-Mediated Ferroptosis and Its Potential Role in Central Nervous System Diseases and Injuries.
Jia B; Li J; Song Y; Luo C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373168
[TBL] [Abstract][Full Text] [Related]
20. Identification of ACSL4 as a biomarker and contributor of ferroptosis.
Yuan H; Li X; Zhang X; Kang R; Tang D
Biochem Biophys Res Commun; 2016 Sep; 478(3):1338-43. PubMed ID: 27565726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
